Products
Human Diploid Hepatitis A Vaccine
If you are looking for a manufacturer that can provide a stable, long-term supply of Human Diploid Hepatitis A Vaccine, you can choose AIM Action Biopharmaceutical Co., Ltd. from China. We produce vaccines using internationally recognized safe human diploid cells (KMB17) as the culture medium, eliminating the potential risk of viral contamination and tumorigenicity associated with animal-derived cells, resulting in a purer and safer product.
AIM Action Biopharmaceutical Co., Ltd. is a professional and reliable vaccine manufacturer and developer. Our Human Diploid Hepatitis A Vaccine has been approved by the China National Medical Products Administration (NMPA), ensuring high quality, safety, and efficacy. It has become a preferred choice for many disease control centers and public health programs, providing an excellent option for those seeking higher standards of vaccination.
Our Technology
The Human Diploid Hepatitis A Vaccine developed and manufactured by AIM Action utilizes normal human lung fibroblasts (KMB17) as its core technology.
This human diploid cell line is used for virus culture and preparation. Compared to traditional animal cells (such as Vero monkey kidney cells), human diploid cells have a normal chromosomal karyotype and are free from the risk of exogenous factor contamination, fundamentally avoiding theoretical concerns about animal-derived DNA residue and potential tumorigenicity.
This means that this vaccine provides you not only with immune protection against the Hepatitis A virus, but also with the ultimate safety assurance achieved through meticulous attention to detail at the cellular level. It is the product of technological advancement, especially suitable for families and institutions with higher demands for vaccine quality and safety.
Why Is Human Diploid Cell the Better Cell Matrix?
The World Health Organization (WHO) and the Chinese National Pharmacopoeia provide clear guidelines for cell matrices used in vaccine production, with human diploid cells being classified as one of the highest safety-grade cell lines due to their unique characteristics.
| Contrast dimension | Human diploid cell (e.g. KMB17) | Non-human animal cells |
| Chromosome characteristics | The normal diploid karyotype, limited passage life, and non-tumorigenicity. | Most of them are non-integer or immortal cell lines, and there is a theoretical risk of tumorigenicity, which should be strictly tested. |
| Source and Risk | It is derived from healthy human tissues and poses no risk of animal-derived pathogens. | It is derived from animals and carries the risk of contamination with potentially animal viruses, and screening is complex. |
| Regulatory bias | Recognized by WHO, China Pharmacopoeia and other national regulatory agencies as one of the safest cell matrices. | It is allowed to use, but there are very strict control standards for its DNA residue and tumorigenicity. |
| Clinical application | It is used to produce vaccines for rabies, chickenpox, hepatitis A and other vaccines with high safety requirements. | It is widely used in the production of many kinds of vaccines, and the technology is mature, but the source risk control requirements are extremely high. |
Core Features: Human-derived Cell-based Safety Assurance
1. Purity, Eliminating Animal Origin Risks: Manufactured from human diploid cells, this vaccine completely avoids potential unknown pathogens or xenogeneic proteins introduced by animal cells such as chicken embryos or hamster kidneys, ensuring purity from the source.
2. Safety: Human diploid cell matrix has been safely used worldwide for decades, is widely used in high-end vaccines such as rabies, chickenpox, etc., and its safety has been clinically validated over a long period of time.
3. The immune response is more natural: The virus is cultured in human cells, and its antigen structure is closer to the shape recognized by the body during natural infection, which may induce a more balanced and lasting immune protection.
4. Wider applicability: With its high safety profile, Human Diploid Hepatitis A Vaccine provides a vaccination option for a wider range of people, including those with immunocompromised status, without the concern of animal-derived allergies.
Main Application Scenarios
For individuals and families with extreme safety requirements: Especially for parents who choose vaccines for their children with attention to every detail of production, or for adults who are concerned about their own immunity.
High-end medical care and international travel health protection: AIM Vaccine’s products are often recommended by the International Travel Health Care Centre to meet the high standards of health protection for overseas work and study.
Public health security projects: They can provide a technical solution with higher safety benchmarks for the CDC to respond to clusters in key populations such as schools and the food industry.
Hot Tags: Human Diploid Hepatitis A Vaccine, China, Manufacturer, Supplier, Factory
Send Inquiry
Contact Info
-
Address
● 26F, T6, Dazu Square, NO.2 Ronghua South Road, ETDZ, Beijing, China
● 10F, Port Building, 1 Fenghe Road, Pudong, Shanghai, China -
Tel
-
E-mail
For inquiries about human rabies vaccine, hepatitis B vaccine, hepatitis A vaccine or price list, please leave your email to us and we will be in touch within 24 hours.
